2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
申请人:Alonso-Alija Cristina
公开号:US20060293326A1
公开(公告)日:2006-12-28
The invention relates to 2-Heteroaryl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases. The present invention relates to compounds of the general formula (I) in which R
1
denotes 5- to 10-membered heteroaryl, which is optionally substituted by identical or different residues selected from the group consisting of halogen, (C
1
-C
4
)-alkyl, trifluoromthyl, cyano, nitro und trifluoromethoxy, denotes 3- to 10-membered carbocyclyl or carbon-bonded, 4- to 10-membered heterocyclyl, whereby carbocyclyl and heterocyclyl are optionally substituted by identical or different residues selected from the group consisting of (C
1
-C
6
)-aldyl, (C
1
-C
6
)-aldoxy, hydroxy, halogen, trifluoromethyl and oxo, or denotes (C
2
-C
10
)-alkyl, which is optionally substituted by identical or different residues selected from the group the group consisting of (C
1
-C
6
)-alkoxy, hydroxy, halogen, 3- to 10-membered carbocyclyl and oxo.
本发明涉及2-杂环芳基咪唑三嗪酮的制备方法及其在药物中的应用,特别是用于治疗和/或预防炎症过程和/或免疫性疾病。本发明涉及通式(I)的化合物,其中R1表示5-至10-成员杂环芳基,该杂环芳基可以被选自卤素,(C1-C4)-烷基,三氟甲基,氰基,硝基和三氟甲氧基的相同或不同残基取代,或表示3-至10-成员碳环烷基或碳键结合的4-至10-成员杂环烷基,其中碳环烷基和杂环烷基可以被选自(C1-C6)-醛基,(C1-C6)-醛氧基,羟基,卤素,三氟甲基和氧代物的相同或不同残基取代,或表示(C2-C10)-烷基,该烷基可以被选自(C1-C6)-氧烷基,羟基,卤素,3-至10-成员碳环烷基和氧代物的相同或不同残基取代。